A nurse is assisting with care of a cient who has a prescription for 3000 ml of intravenous huias over the nes:24 hr The nurse should set the IV pump to deliver how many mL/hr? (Round to the nearest whole number)

A) Transdermal patch:
Transdermal patches are designed for slow, continuous delivery of medication through the skin over a long period of time, typically 24 hours. Although they provide steady medication levels, they do not offer a rapid onset of action. This route is more suitable for long-term control of conditions like angina but is not the fastest for immediate relief.

B) Topical ointment:
Topical ointments are applied to the skin and absorb slowly. While they may have local effects, they are not used for quick systemic effects. In the case of nitroglycerin, topical ointments are generally used for sustained release over several hours and are not intended for immediate relief of chest pain.

C) Suspended release:
Suspended release formulations are designed to release the drug slowly over time. Like transdermal patches, these formulations are meant for long-term management, not for rapid onset. A suspended release formulation of nitroglycerin would not provide the immediate relief that is typically needed in cases of acute angina or chest pain.

D) Sublingual:
The sublingual route provides the most rapid onset of action for nitroglycerin. When nitroglycerin is placed under the tongue, it is absorbed directly into the bloodstream through the mucous membranes of the mouth. This bypasses the digestive system and the liver (first-pass metabolism), allowing the drug to take effect quickly—usually within 1 to 3 minutes—making it ideal for acute relief of chest pain or angina. This route is commonly used for emergencies when rapid relief is needed.

A) Drug Enforcement Administration (DEA)
The DEA is primarily responsible for enforcing the controlled substances laws and regulations, including monitoring the manufacturing and distribution of drugs that are classified as controlled substances. While the DEA plays an important role in regulating drugs, particularly those that have a high potential for abuse, it is not the primary authority on drug standards or approval processes.

B) Food and Drug Administration (FDA)
The FDA is the primary authority responsible for drug standards in the United States. The FDA regulates the safety, efficacy, and quality of pharmaceutical drugs, vaccines, biologics, and medical devices. It is responsible for approving new medications, ensuring they meet rigorous standards for safety and effectiveness before they are made available to the public. The FDA also monitors drugs after they are approved, requiring post-market surveillance and, if necessary, issuing recalls or safety warnings.

C) Centers for Disease Control and Prevention (CDC)
The CDC is focused on public health and disease prevention rather than the regulation of drugs. The CDC plays an important role in providing guidelines for the treatment and prevention of diseases, offering recommendations for vaccination schedules, and conducting epidemiological research.

D) National Institutes of Health (NIH)
The NIH is a leading medical research organization that conducts and funds biomedical research. While the NIH plays a crucial role in advancing scientific knowledge and supporting the development of new treatments, it does not have the authority to regulate or set standards for drugs.